A study of prevalence of cardiomyopathy in diabetes mellitus as evidenced by electrocardiography and 2-D echo


  • Pankaj Garg GMERS Medical College, Gandhinagar, Gujarat, India.
  • Savita Jindal Department of Pulmonary Medicine, Civil Hospital, B.J. Medical College, Ahmedabad – 380016, Gujarat, India
  • Chirag Gangajalia Department of Pulmonary Medicine, Civil Hospital, B.J. Medical College, Ahmedabad – 380016, Gujarat, India




Cardiomyopathy, Diabetes


Background: Diabetic cardiomyopathy is characterized by diastolic dysfunction, which is rarely clinically apparent unless associated with hypertension and/or with myocardial ischemia. The aim of the study was to determine the prevalence of cardiomyopathy in diabetes mellitus.

Methods: This study was carried out on patients coming as out patients (100) to Dr. D.Y.Patil Hospital & Research Centre, Nerul Navi Mumbai from June 2006 to December 2008.

Results: In this study maximum number of diabetics are between the age group of 41-50. Males (65) are more common than female (35). Main complaints of the patients coming to OPD was chest pain (59%), followed by giddiness (48%), breathlessness (47%), sweating (33%). ECG changes does not have any correlation with duration of DM. ECG changes related to cardiomyopathy were present in 38 out of 65 males and 25 out of 35 females i.e. total number of 63 subjects had ECG changes related to diabetic cardiomyopathy. 28 males and 16 females had diastolic dysfunction in 2 D Echo. Maximum numbers of patients with diastolic dysfunction were between the age group of 51-60 years in male and females i.e. 11 and 08 respectively. 46 patients had mild systolic dysfunction. 40 patients had normal systolic function but 13 patients had moderate systolic dysfunction while only 01 patient had severe systolic dysfunction.

Conclusions: Prevalence of cardiomyopathy in diabetes in present study as evidenced by ECG is 63% and by 2 D Echo it is 62%. Patient with DM of 5 years of duration, should be properly screened & put on proper inotropic drugs to prevent the worsening of diabetic cardiomyopathy.


Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, et al.Diastolic Dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well controlled type 2 Diabetes Mellitus. J Am Coll Cardiol. 2003;42:328-35.

Fein FS. Diabetic Cardiomyopathy. Diabetes Care. 1990;13:1169-1179.

Am J Physiol Heart Circ Physiol 291: H1489- H1506, 2006.

Ahmed SS, Jafer GA, Narang RM, et al. Preclinical abnormality of left ventricular function in diabetes mellitus. Am Heart J. 1975;89:153-8.

Blomhe G et al. Diabetilogia. 1992;35(1):56-62.

Votey SR, et al. Diabetes Mellitus type 2 – A Review Endocrine July 2008.

Sohn D W, Chai IH , Lee DJ , Kim HS, Oh BH, Lee MM, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol. 1997;30:474-80.

Regan TJ, Lyons MM, Ahmed SS, Levison GE, Oldewurtel HA, Ahmad MR, et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest. 1977;60:884-99.

Redfield MM, Jcobsen SJ, Burnett JC, Mahoney DW, Bailey KR, et al. Burden of systolic and diastolic ventricular dysfunction in the community. JAMA. 2003;289:194-202.

Poirier P, Bogaty P, Garneau C, Marois L, et al. Diastolic dysfunction in normotensive men with well controlled type 2 diabetes:importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 24:5 10, 200.






Original Research Articles